MetaCap

Orthofix Medical (OFIX) vs Pro-Dex (PDEX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Pro-Dex (PDEX) has outperformed Orthofix Medical (OFIX) over the past year, gaining 92.9% versus a loss of 60.2%. Over five years, PDEX leads with a +180.2% price change compared with -80.6% for OFIX. Orthofix Medical is the larger company by market cap ($247.4 million vs $201.6 million), about 1.2 times the size, while Pro-Dex is growing revenue faster (+16.5% vs +2.9%).

On valuation, Pro-Dex trades at a lower forward P/E (18.2x vs 33.7x for Orthofix Medical). Pro-Dex converts more of its revenue into profit, with a net margin of 17.6% versus -11.2%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

OFIX-60.22%PDEX+92.90%
+134%+32%-69%
Nov 21, 20251 yearNov 20, 2026
OFIX-80.46%PDEX+208.22%
+276%+89%-97%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

OFIX versus PDEX key metrics
MetricOFIXPDEX
Share price$6.07$63.00
Market cap$247.41M$201.60M
1-day change-4.26%-0.77%
YTD return-59.96%+63.72%
1-year return-60.22%+92.90%
5-year return-80.64%+180.25%
P/E ratio (TTM)—17.36
Forward P/E33.7218.16
EPS (TTM)$-1.10$3.63
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$822.31M$77.55M
Revenue growth (YoY)+2.85%+16.45%
Net income (latest FY)$-92.19M$13.66M
Gross margin68.83%31.38%
Operating margin-9.90%16.75%
Net margin-11.21%17.62%
52-week high$16.42$77.00
52-week low$6.04$32.14
Distance from 52-week high-63.03%-18.18%
Analyst consensusbuystrong_buy
Avg. price target upside+64.74%+26.98%
Average volume481.16K54.15K
Shares outstanding40.76M3.20M
Employees1,605201
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • PDEX has outperformed OFIX by 153.1 percentage points over the past year.
  • Pro-Dex is more profitable, keeping 17.6 cents of every revenue dollar as net income versus -11.2 cents for Orthofix Medical.
  • Pro-Dex grew revenue faster in its latest fiscal year (+16.45% vs +2.85%).

About Orthofix Medical

OFIX stock →

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction.

Health Care · Medical/Dental Instruments · 1,605 employees

About Pro-Dex

PDEX stock →

Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide.

Health Care · Medical/Dental Instruments · 201 employees

OFIX vs PDEX FAQ

Which is bigger, Orthofix Medical or Pro-Dex?

Orthofix Medical (OFIX) is larger, with a market capitalization of $247.41M compared with $201.60M for Pro-Dex (PDEX).

Which stock has performed better over the past year, OFIX or PDEX?

PDEX returned +92.90% over the past 12 months, compared with -60.22% for OFIX (price return, excluding dividends). Past performance does not predict future results.

Are Orthofix Medical and Pro-Dex in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons